Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 1 × INDUSTRY × MK-4166 × Clear all

Phase

Status

Sponsor Class

OTHER 1 INDUSTRY 1

Study Type

Interventional 1

Sponsor

Cancer Type

Other solid neoplasm 1

Conditions

Interventions

pembrolizumab 301 Paclitaxel 204 Carboplatin 198 Gemcitabine 172 Cisplatin 138 Docetaxel 137 Cyclophosphamide 134 Nivolumab 130 Bevacizumab 117 Injections 111 fludarabine 94 atezolizumab 92 Pemetrexed 90 Dexamethasone 89 Cetuximab 89 Fluorouracil 83 Irinotecan 76 Rituximab 72 Capecitabine 72 venetoclax 70 Azacitidine 70 130-nm albumin-bound paclitaxel 67 Leucovorin 64 Oxaliplatin 57 Trastuzumab 56 durvalumab 55 Lenalidomide 55 Ipilimumab 55 Fulvestrant 55 Midazolam 54

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT02132754 2021-01-28

MK-4166-001

Merck Sharp & Dohme LLC

Phase 1 Completed

116 enrolled 61 charts

Other solid neoplasm

Solid Tumor

Data powered by HemOnc (CC BY 4.0) Colophon ⚡